- Prostate cancer
Professor Chris Parker qualified in medicine from Oxford University in 1989. He trained in oncology at The Royal Marsden and gained his FRCR in 1996. After a research fellowship in Toronto, he was appointed Senior Lecturer and Honorary Consultant in Clinical Oncology and Prostate Cancer Translational research at The Institute of Cancer Research and The Royal Marsden in 2001.
His clinical practice concerns the management of prostate cancer. Research interests include active surveillance of low-risk disease, post-operative adjuvant therapy, and radionuclide therapy for advanced disease. He is a former Chair of the National Cancer Research Institute Prostate Clinical Studies Group. He has published over 250 articles on prostate cancer.